Birdwatch Archive - Rating Details

Birdwatch Note Rating

2023-08-25 22:20:41 UTC - SOMEWHAT_HELPFUL

Rated by Participant: B34A537A40F2AFC3907BCB0372C59830C038DB980A55CED90F9B356AC199A49F
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

noteId - 1695190002055970932
participantId -
raterParticipantId - B34A537A40F2AFC3907BCB0372C59830C038DB980A55CED90F9B356AC199A49F
createdAtMillis - 1693002041950
version - 2
agree - 0
disagree - 0
helpful - 0
notHelpful - 0
helpfulnessLevel - SOMEWHAT_HELPFUL
helpfulOther - 1
helpfulInformative - 0
helpfulClear - 0
helpfulEmpathetic - 0
helpfulGoodSources - 1
helpfulUniqueContext - 0
helpfulAddressesClaim - 0
helpfulImportantContext - 1
helpfulUnbiasedLanguage - 0
notHelpfulOther - 0
notHelpfulIncorrect - 0
notHelpfulSourcesMissingOrUnreliable - 0
notHelpfulOpinionSpeculationOrBias - 0
notHelpfulMissingKeyPoints - 0
notHelpfulOutdated - 0
notHelpfulHardToUnderstand - 1
notHelpfulArgumentativeOrBiased - 0
notHelpfulOffTopic - 0
notHelpfulSpamHarassmentOrAbuse - 0
notHelpfulIrrelevantSources - 0
notHelpfulOpinionSpeculation - 0
notHelpfulNoteNotNeeded - 0
ratingsId - 1695190002055970932B34A537A40F2AFC3907BCB0372C59830C038DB980A55CED90F9B356AC199A49F